We examined the dynamics of clot growth in vitro and found, that initially the clot grows at a constant speed, then abruptly stops and becomes surrounded by an "inhibition zone" in which coagulation is strongly suppressed. We also observed formation of "stratified structures" (target patterns) in which solid layers alternate with liquid blood. The experimental results strongly support a hypothesis that blood is a new type of excitable medium.
Introduction
The process of blood coagulation is characterized by a complex time and spatial organization. To stop bleeding, the damaged area must be quickly and completely sealed with a clot. It is equally dangerous for an organism to form an insufficiently sized clot or to form a clot accidentally in another area or at the wrong time. The spatio-temporal dynamics of clot formation remains poorly understood, because size, shape and structure of clot are usually studied using statical methods, e.g. histological [Johnson & Guest, 1969] . These methods do not answer important dynamic questions concerning the rate of clot growth, nature of the factors that define this rate and control the size of the clot, and how the clot growth is terminated.
In this work we studied and analyzed the dynamics of thrombin production and fibrin polymerization during clot growth in vitro. We found that initially a clot grows at a constant speed but then abruptly stops. The resulting thickness of the clot is almost independent of the initiating signals. The clot becomes surrounded by an "inhibition zone" in which coagulation is strongly inhibited. Sometimes the normal pattern of clot growth is disrupted and "stratified structures" are formed in which solid layers alternate with liquid blood. We also observed continuous clot growth. The "inhibition zones" and the "stratified structures" can not be easily explained from the classical point of view on the clotting process. However, these data agree well with a hypothesis of clot growth as consisting of three distinct phases: the initiation, elongation and termination. In this hypothesis the intrinsic pathway is responsible for the second, elongation phase of clot growth in which thrombin propagates as a self-sustained wave. Our hypothesis offers a new concept of blood coagulation, which is considered as a new type autowave process.
Materials and Methods
Plasma and Reagents: Experiments were performed on platelet poor plasma (PPP), unless specified otherwise. PPP was isolated from random-donor blood units by conventional bloodbank centrifugation techniques. Triple blood pack systems (Baxter, S. A. de C. V., Morelos, Mexico) containing CPD in the primary bag were used for blood collection. Whole-blood units were centrifuged at 1000 g for 10 min at 22 • C. The platelet rich plasma (PRP) was transferred in a satellite bag and centrifuged at 2400 g for 20 min at 22 • C. The supernatant plasma (PPP) contained less than 2 · 10 10 platelets/l. It was stored in PVC transfer bags at room temperature for no longer than two days. Platelet free plasma (PFP) was obtained by centrifuging the PPP in the 4 ml plastic tubes at 10,000 g for 20 min at 22 • C. PRP, PFP and whole blood were used on the day of blood collection or next day. A specific fluorogenic substrate for thrombin BOC-Ala-Pro-Arg-AMC (substrate S) was synthesized by Dr. V. Pozdnev at the Institute of Biological and Medical Chemistry, Russian Academy of Medical Sciences. Substrate S was prepared as a 10 mM stock solution in dimethyl sulfoxide and added to plasma or blood to a final concentration of 0.05 mM.
Visualization and Registration of Clot Growth: Aliquots (1 ml) of PPP, PFP, PRP or whole blood were placed into 35 mm polystyrene Petri dishes (Medpolimer, St. Petersburg, Russia) to obtain desired liquid layers 0.5-3.0 mm thick. pH of PPP and PFP was stabilized at 7.2-7.6 by adding 0.1-0.15% of lactic acid directly to the dishes and incubating them at 37 • C for 40-60 min prior to the experiments. The Petri dish was then placed into a temperature-controlled chamber [ Fig. 1(a) ] and incubated for 1-5 min to equilibrate the temperature. Plasma (or blood) was recalcified with 1 M calcium chloride (Sigma, USA) to achieve free calcium concentration 1.5-2.0 mM. The concentration of free calcium in plasma (or blood) was determined with a calcium electrode in a pair with a reference electrode (Model 90-02) attached to the EA 920 meter (Orion Research AG, Kusnacht, Switzerland).
To initiate clotting we added a glass bead approximately 0.6 mm in diameter [ Fig. 1(a) ] to the center of Petri dish ( Fig. 1; 1) . In some experiments, collagen fibers (Serva, Germany) or thrombin (Merck, Germany) were used instead of glass beads. Precautions were made to leave the plasma almost undisturbed. The dish was then sealed • C) with a quartz window (3); (4) a UV-light source (mercury bulb); (5) aqueous heat-absorbing filters and UV glass filter with a band pass 300-380 nm; (6) semitransparent dichroic mirror; (7) chamber with plasma; (8) CCD camera; (9) computer; (10) set of red diodes.
with a lid and placed in thermostating container ( Fig. 1; 2 ) with a quartz window ( Fig. 1; 3) . These temperature-controlling conditions excluded a condensation of moisture inside the dish and allowed direct visualization of the clotting processes. Moreover, the thermostating minimized the convective heat flows, as was determined by adding 50 µl of Indian ink or some chalk powder into the plasma. During 2 h incubation under these conditions there was no detectable vertical and horizontal mixing. The spreading patterns were, therefore, determined by the diffusion and the convective flows contribute insignificantly.
The formation of thrombin was monitored using the fluorescence produced by AMC which thrombin cleaves from substrate S. The spatial AMC distributions were recorded using the computer-assisted laboratory setup shown in Fig. 1(b) . Light from a mercury lamp ( Fig. 1; 4) passed through an aqueous heat-blocking filter and a glass filter ( Fig. 1 ; 5) blocking visible part of the spectrum and impinged on a semitransparent dichroic mirror ( Fig. 1; 6 ) that was placed in the light path so that the chamber with plasma ( Fig. 1; 7) was illuminated from below. The filters and the mirror provided narrow-band light with a maximum at 380 nm to excite AMC fluorescence. The maximum of AMC fluorescence is at 440 nm. The mirror was transparent at this wavelength. The fluorescence signal was recorded with a digital CCD camera (Electrim Corporation, USA) ( Fig. 1; 8 ) mounted under the mirror. The image of an area measuring 9 × 6.5 mm (which could be chosen in any part of the polystyrene chamber) was transferred from the RGB matrix of the CCD camera to the computer and displayed on the monitor screen. The data were saved as files for the offline analysis.
To calibrate the AMC fluorescence signal, AMC of a known concentration was added to the plasma, and its image (calibration frame) was recorded. The calibration frame was used to normalize the fluorescence signals recorded during the experiment. The results were expressed in AMC concentration units. The spatial nonuniformity of UV illumination of the chamber was also eliminated by this calibration procedure.
The formation of fibrin-polymer was monitored by light-scattering. Light from the set of red diodes (λ = 690 nm) ( Fig. 1; 10 ) illuminated the chamber with plasma from below. The scattered light passed through semitransparent mirror ( Fig. 1; 6 ) and was registered with a CCD camera ( Fig. 1; 8) .
Determination of thrombin activity
Thrombin activity was determined fluorometrically on a JY 3D instrument (Jobin Yvon, France) from the hydrolysis rate of BOC-Ala-Pro-Arg-AMC. Fluorescence of AMC was recorded using the excitation and emission wavelengths of 380 and 440 nm, respectively. Thrombin activity was calculated from the initial hydrolysis rates of the substrate and the kinetic constants k cat = 130s −1 and K M = 13 µM for this reaction available from the literature [Kawabata et al., 1988] . The signals recorded were calibrated by comparison with the signal from 1 µM AMC in the same buffer. FITC-thrombin was conjugated to fluorescein isothiocyanate (FITC; Sigma, USA) at the Institute of Immunology (Ministry of Health, Moscow, Russia) according to the method described in [Hudson & Hay, 1989 ].
Clot growth during thrombin diffusion into nonrecalcified plasma
A special polystyrene chamber [ Fig. 1(c) ] was used to study the spatio-temporal dynamics of clot formation and changes in activity of the thrombin entering nonrecalcified PPP or fibrinogen solution by diffusion. The chamber consisted of two compartments separated with a thin polyethylene terephthalate film with 3-µm pores (Joint Institute for Nuclear Research, Dubna, Moscow Oblast, Russia). The membrane mechanically prevented the solutions in the compartments from immediate admixing upon filling but allowed diffusion of thrombin and other plasma proteins through its 3-µm pores. Each compartment was 300 µl in volume and 1 mm in height. Convective flows are unavoidable in such a small chamber; therefore, in order to prevent distortion of the spatial distribution of coagulation factors caused by convection, melted agarose polymerizing at 36 • C was added to the nonrecalcified plasma supplemented with 100 µM Boc-Ala-ProArg-AMC and preheated to 38 • C. The final agarose concentration in plasma was 0.2%; all additions to the plasma accounted for no more than 4% of its volume. The agarose-plasma mixture was transferred to one of the compartments that was kept at room temperature and allowed to polymerize. The chamber was then placed in the thermostat of the experimental setup that was kept at 37 • C throughout the experiment. Immediately before the experiment, the other compartment was filled with thrombin of known concentration (in the range from 50 to 400 nM). The interval between the moment of filling the second compartment with thrombin and the start of recording was no more than 1.5 min.
Results

Dynamics of clot growth
To examine the dynamics of clot growth in vitro, Petri dish with a thin layer of whole blood supplemented with the AMC-labeled substrate S was placed in a specially designed chamber with thermostating conditions (see Sec. 2). Two to three minutes after addition of the glass beads to initiate clotting, one can see appearance of the narrow, bright fluorescent zones around the beads [Ataullakhanov et al., 1998 ]. This fluorescence is produced by AMC cleaved from the substrate S by thrombin, which becomes activated during clotting. The fluorescent zones grow quickly until they reach 0.5 mm in thickness and then stop [ Fig. 2(a) ]. While growing, the edges of the fluorescent zones are very sharp, implying that the rate of growth is faster than the diffusion of the fluorescent product. The diffusion becomes apparent after the clots stop growing, leading to the slow fading of the bright areas. At this moment the liquid blood can be removed from the dish to expose the clots [ Fig. 2(b) ]. As expected, the size of the clot is identical to the size of the bright zone. Thus, clot growth in vitro has the characteristic features of the clotting in vivo: the clots are produced around the activating centers and do not spread all over the liquid blood. The abundance of red blood cells makes it difficult to monitor clot growth continuously. When the red cells are removed, the remaining plasma behaves identically to blood and clot growth can be easily monitored by light scattering of fibrinpolymer (Fig. 3) or fluorescence of AMC (Fig. 4) . 2). The clotting was induced by the addition of a glass bead. The frames are separated by three minutes interval except for the last image, which was taken one hour later. Note that after the clot has stopped growing the fluorescent product slowly dissipates.
activation as visualized by AMC fluorescence (Fig. 4) . Initially, the bright fluorescent zones of AMC grow fast ]. These zones have sharp edges, but when the clots stop growing, the AMC diffusion becomes apparent. The AMC leaves the clots and spreads all over the Petri dish, so that one hour after the clot stopped growing the fluorescence in the clot area becomes very weak [ Fig. 4(i) ]. dependence as in c but for optical density. In (a) and (b) different curves represent different times after initiation of the growth: the first curve was recorded 13 min after the start of the experiment; all other curves were recorded every 5 min after the first one. Clotting was activated in plasma by addition of a glass bar [as in Fig. 2(c) ], so that the clot was growing as a flat front in a direction parallel to the bottom of the dish. The amount of light scattering material (b) was detected by its optical density. Fluorescence (a) was registered simultaneously by switching from a red light source to the UV one. Other conditions were as for Fig. 2(c) . Intensity of AMC fluorescence is proportional to the total AMC concentration, therefore thrombin activity is proportional to the increment of AMC fluorescence.
cent dye AMC, one can see that initially thrombin activity rises quickly near the activating surface, but then abruptly falls. The wave of AMC fluorescence starts propagating from the surface, so that its front remains almost identical for different points in time up until the wave stops. The initial speed of thrombin front propagation and clot growth is about 0.05-0.1 mm/min under these conditions. Since fluorescent zones do not remain localized to the clot area for a long time, it seems highly unlikely that AMC or substrate S could bind or become trapped in the clot. In order to examine whether the localized distribution of the fluorescent zones (i.e. distribution of the AMC) was due to the binding of the substrate S and/or AMC to the fibrin, which forms fabrics of the clot, we performed the following experiments. Platelet poor plasma (PPP) was supplemented with 5 µM AMC (or substrate S) and placed into a fluorometer cuvette. Then, the thrombin was added to initiate the clotting, while stirring continuously. Under these conditions, fibrin threads become trapped around the stirring bar. If AMC (or substrate S) were binding to the fibrin, one would expect a decrease in the fluorescent signal coming from the liquid phase. Since no such decrease was observed, we concluded that fibrin does not bind AMC (or substrate S).
In the second set of experiments the PPP was supplemented with 5 µM AMC (or substrate S), and after recording the resulting fluorescent signal, the thrombin was added to initiate clotting without stirring. After coagulation was completed the clots were sedimented by centrifugation, and the fluorescence of the supernatant serum was recorded. The resulting signal was 96% of the initial level, and, hence, a loss of 4% could be accounted for the AMC (or substrate S) binding to the clots. The bound AMC (substrate S) was not sufficient to cause any significant fluorescence, as we could not detect fluorescence from these clots placed in a saline buffer. We, therefore, concluded that spatial distribution of AMC fluorescence during clot growth could not be explained by the AMC or substrate S binding to the clots. curves show how the recorded parameter changes in space along an arbitrarily chosen scan line in the direction perpendicular to the membrane. Each figure shows a family of curves recorded along the same line at various times from the start of the experiment. As the images are symmetrical with respect to the normal to the membrane, the choice of the line had little or no effect on the curves: we obtained similar curves when varying the scan line position. The diffusion profiles of FITC-thrombin are similar in buffer and plasma [Figs. 6(a) and 6(b)]. In plasma, a clot grew on the membrane, whereas in buffer, the membrane remained free of clot growth throughout the experiment. By the end of the experiment (2 h), thrombin spread over a distance of about 1.5-2 mm.
Dynamics of clot growth induced by thrombin diffusing into nonrecalcified plasma: Effects of various thrombin concentrations
Thrombin entering the plasma compartment induced the formation of a solid fibrin clot, i.e. the structure denser than the surrounding plasma. Light scattering increased in the area of clot formation above the background level observed initially in the plasma (this initial value of light scattering was taken as zero). The spatial profiles of light scattering observed in plasma for the concentrations of diffusing thrombin of 50 and 400 nM are shown in Figs. 7(a) and 7(b), respectively. In both cases, the area of increased scattering was localized to the membrane and had clear-cut edges that characterized the clot shape. Two stages were evident in the dynamics of changes in the light scattering by the clot. At the first stage, which was 30-45 min long, the intensity of light scattering by the rapidly growing clot increased. The area of increased light scattering expanded to a distance of 0.3-0.5 mm from the membrane. During the subsequent 1.5 h, the spatial boundary of the clot remained almost unchanged; however, the intensity of light scattered by the area occupied by the clot continued to increase, but at a rate considerably lower than the rate observed during the first minutes of clot growth. As evident from comparison of Figs. 7(a) and 7(b), the dynamics of clot formation and its geometric characteristics only weakly depended on the thrombin concentration in a broad range. However, the clots that grew in plasma depleted of ATIII to 5% of its initial content, were greater in size (Fig. 8) .
Platelets role in the dynamics of clot growth
It is well known that platelets participate in the formation of primary clots in vivo, so we wanted to examine how they influence the clot growth in Figure 10 shows propagation of the fluorescent zones at initial stages of clot growth around the glass beads as a function of platelets concentration. The initiation of clotting and rate of clot growth are virtually identical in platelet poor and platelet rich plasma. We observed slightly slower rate of the clot growth in platelet free plasma, but the difference is statistically insignificant. We, therefore, concluded that the platelets stimulate formation of the clots in vitro, but they do not influence significantly the dynamics of clots growth. . Surprisingly, we found that the rate of clot growth and the clot thickness were independent of the size and shape of the activating objects. Nor did it depend on thickness of the plasma layer, which was six times larger in Fig. 2(c) , than in Fig. 2(d) . We then initiated clot growth from different activating materials, such as collagen fiber [ Fig. 2(d) ] or powdered thrombin [ Figs. 2(e)-2(g)]. We found that the smaller the activation, the longer the lag period, but the rate of clot growth and the thickness of clots were almost identical in all cases examined. The powdered thrombin initiates the wave of activated thrombin immediately upon contact with plasma. The bright area expands quickly but then abruptly stops [ Fig. 2(f) ], so that the resulting thickness of the clot is almost identical to that of the clot formed around the glass bead [ Fig. 2(g) ]. Same effect is seen in PPP without calcium (free calcium concentration < 50 µM). Paradoxically, the amount of added thrombin vastly exceeded the amount necessary to cause complete clotting of the plasma in the dish. Indeed, clotting occurs quickly if the contents of the dish are stirred continuously. We also found that same amount of powdered thrombin could cause clotting in the whole dish without stirring, if fibrinogen solution was substituted for plasma (not shown). These results strongly suggest that special mechanism(s) limiting the clot growth exist in plasma, but not in the fibrinogen solution. They also imply that this mechanism(s) cannot be attributed to thrombin binding to the clot, since clot grows uninterrupted in the fibrinogen solution.
In vitro clotting may occur spontaneously, as shown in Figs. 2(d) and 9 . These spontaneous centers of activation occur later, but the clots grow by the same scenario and stop growing when they reach the same thickness as the nonspontaneous clots (not shown). The number of spontaneous centers strongly depends on platelets concentration (Fig. 9) . It is likely that the aggregates of platelets serve as the origins of spontaneous clotting. Eventually the whole dish becomes covered with the clots which fuse if they grow close together. Surprisingly, if the distance between the clots is approximately twice the characteristic size of a single clot, the clots do not fuse, but instead inhibit each other's growth [ Fig. 11(a) ]. Between the clots, one can see a narrow channel of blood which remains liquid for many hours, implying that clotting is inhibited in this area. These "inhibition zones" eventually cover the whole dish in a network of liquid blood channels [ Fig. 11(b) ]. The long linear "inhibition zones" between the clots suggest that the clots grow with the same speed towards each other, but cannot get closer than a certain distance -width of the "inhibition zone".
Formation of the stratified structures
Sometimes the normal pattern of clot growth is disrupted (Fig. 12) . Soon after the normal clot growth has stopped, we observed the growth of a second layer. This second layer starts growing at some distance from the first clot, approximately equal to the width of the "inhibition zone" [ Fig. 12(c) ]. The "inhibition zones" around different clots fuse together forming the surface from which the second layer starts growing. This growth proceeds similarly to normal clot growth and when it stops, the third layer may start growing after some lag [ Fig. 12(d) ]. In these "stratified structures", which look similar to the so-called target patterns, the solid layers alternate with areas in which blood remains liquid for many hours. Formation of the stratified structures is easier to observe if growth of the spontaneous clots is suppressed. Experimentally this can be achieved by lowering the concentration of free calcium in plasma. Often the second layer is much weaker than the original clot, so that it cannot be observed by light scattering, but it can be visualized by staining with the protein binding dye crystal violet (Fig. 13) . In these cases, the third layer is virtually undetectable. Freshly prepared plasma is usually hyperactivated during several hours after drawing. In this plasma we observed clotting in which the initial fast and linear phase of growth is followed by a phase of Fig. 13 . The "stratified structures". 40 min after the initiation of clotting, the liquid plasma was removed, the dish was rinsed once and stained with violet crystalline. Calcium concentration 0.2 mM.
steady and slower growth. The density of the slower growing layer is noticeably lower than that of the original clot.
Discussion
Kinetics of blood coagulation in homogeneous systems
Let us first consider the kinetics of blood coagulation in homogeneous systems. Extensive and thorough studies in this field by numerous researchers provided a detailed analysis of the molecular mechanisms and kinetics of both extrinsic and intrinsic pathways (reviewed in [Fenton, 1988; Fujikawa & Kisiel, 1991] ). The cascade of proteolytic reactions of the extrinsic pathway is triggered by the thromboplastin produced by damaged cells, while the intrinsic pathway is activated when factor XII comes into contact with a foreign surface. Both enzymatic pathways lead to the production of thrombin, which is a key clotting factor. Thrombin cleaves the fibrinogen to produce fibrin-monomers, which polymerize into fibrin fibers. Thrombin is also a key regulator of the clotting cascades, because it is involved in many positive and negative feedbacks on these pathways [Walz et al., 1986; Colman et al., 1993; Berliner 1992] . The prominent feature of the kinetics of clotting is its threshold behavior in response to activation [Lawson et al., 1994; Willems et al., 1991; Esmon, 1989] . When activating signals are small the active forms of the clotting factors are quickly inactivated by the clotting inhibitors, which are abundant in plasma. Under these conditions the steady-state concentrations of active factors are proportional to the activating signal. These concentrations are too low to cause measurable production of fibrin or even to be detected. Theoretical calculations for activation signals below the threshold estimate the steady-state concentrations of the active factors as 10 −4 -10 −5 of their precursor concentrations [Travis & Salvesen, 1984] . The kinetics of production of active factors change dramatically when activation threshold is exceeded. Thrombin concentration increases exponentially by 10 3 -10 4 times and becomes comparable with the prothrombin concentration. The high rate of thrombin production results from the positive feedbacks in the pathway, such as activation of cofactors V and VIII by thrombin. This leads to a formation of tenase and prothrombinase complexes, which accelerate thrombin production more than ten thousand times [Jesty, 1986; Khanin & Semenov, 1989; Ataullakhanov et al., 1994a] . After reaching its maximum, the concentration of thrombin falls rapidly to its original level due to the initiation of negative feedback via activation of protein C by thrombin and due to the inhibitors of thrombin constantly present in plasma. Active protein C cleaves active cofactors Va and VIIIa thereby destroying both tenase and prothrombinase complexes, and the rate of thrombin generation decreases [Walker & Fay, 1992] .
Thus, suprathreshold activation of blood or plasma via the extrinsic and the intrinsic pathways causes the impulse of thrombin concentration with an amplitude, which is sufficient for a rapid formation of the solid clot. Simulation analysis of these cascade pathways and their positive feedbacks predicts similar amplitude of thrombin impulse for both pathways and that this amplitude is almost independent of the amplitude of activating signal if it exceeds the threshold. However, the time which takes to reach the maximal amplitude of thrombin concentration does depend on both the amplitude and nature of the activating signal [Travis & Salvesen, 1984; Zarnitsina et al., 1996b] .
It should be noted that the existence of certain reactions of the clotting cascades is still ambiguous. For example, purified to homogeneity thrombin can activate factor XI in vitro albeit at a low rate [Gailani & Broze, 1991] , but whether this reaction takes place in vivo and its possible physiological significance are still unknown [Brunnee et al., 1993; Gailani & Broze, 1993; Von dem Borne et al., 1995; Colman & Scott, 1996] . The contribution of this reaction into the overall kinetics of coagulation for homogeneous systems is insignificant, because activation of factor XI all over the stirred volume by activating signals considerably exceeds its activation by thrombin [Zarnitsina et al., 1996b] .
Spatio-temporal dynamics of blood clotting
We undertook a novel and seemingly promising experimental approach to study the spatio-temporal dynamics of blood clotting processes. In previous theoretical works we have shown that some dynamical aspects of clotting could not be addressed in the experiments with stirring [Ataullakhanov & Guria, 1994; Zarnitsina et al., 1996b] . Here, we directly examined the dynamics of clot growth in vitro using the fluorogenic substrate for thrombin and found that the clot growth in vivo and in vitro has similar dynamic characteristics.
The experimental results allow us to define factors that determine the rate of clot's growth. The area in which the thrombin activity is high fills up quickly with the polymerized fibrin, so it appears that the rate of clot growth is determined by the kinetics of thrombin generation and propagation. The distribution of the fluorescent product of the substrate S cleavage by thrombin suggests that the thrombin pulse is generated near the activating surface. Thrombin concentration rises quickly and then abruptly falls, so that the cleavage of substrate S [ Fig. 5(a) ] and generation of fibrin [Fig. 5(b) ] are almost completely abolished. Initially, the generated pulse of thrombin activity propagates from the activating surface without changing its shape, with approximately the same amplitude and at a constant speed. It appears that the front of thrombin activity propagates in a self-sustaining manner. The autocatalytic character of thrombin generation at this stage agrees well with the exponential production of thrombin in the in vitro stirred systems [Fenton, 1988; Lawson et al., 1994; Kessels et al., 1994] .
The waves that propagate without attenuation are well known. Examples of such waves include propagation of a neuronal impulse [Hodgkin & Huxley, 1952; Krinskii et al., 1978] and excitation in a Belousov-Zhabotinsky reaction [Zhabotinsky & Zaikin, 1970] . The media that allows an excitation to propagate without dissipation is called active or excitable media [Field & Berger, 1986] . It is well known from the theory of active media that nonlinear, nondissipative waves (autowaves) can propagate in the reaction-diffusion systems with autocatalytic kinetics. Parameters of the autowaves, such as their speed and amplitude, are independent of the initiation signals and are defined only by internal kinetic parameters of the system [Zhabotinsky & Zaikin, 1970; Field & Berger, 1986] .
We propose that propagation of thrombin generation during clotting has an autowave nature. The observed constancy of the speed and amplitude of the thrombin wave at the initial stages of clot formation supports our hypothesis. As we have shown (Fig. 2) , the final thickness of the clot is almost completely independent of the size, shape and material of the activating objects. This means that the dynamics of clot growth is mainly determined by the molecular-kinetic properties of the biochemical reactions of clotting, but not by the activating signals. The independence of the wave's parameters from the initiation signals is a characteristic feature of the active media.
However, if the thrombin wave is an autowave, how can it stop in the isotropic space? In all active media known to date, autowaves propagate without attenuation until they reach the boundaries of the media [Hodgkin & Huxley, 1952; Zhabotinsky & Zaikin, 1970; Krinskii et al., 1978 , Field & Berger, 1986 . The existence of special mechanism(s) that stops propagation of the thrombin wave is implied by the "inhibition zones" in which plasma becomes highly "anticoagulant". We used mathematical models to analyze the possible role of inhibitors of clotting in this process and found that the complete stoppage or abrupt deceleration of the wave at a macroscopic distance from the point of initiation in the isotropic space cannot be caused by the preexisting inhibitors. A detailed description of mathematical model and analysis of possible mechanisms of blood clotting can be found in the second part of our work: "Spatio-temporal dynamics of clotting and pattern formation in human blood. A theoretical approach."
